1. Home
  2. LSTA vs CPIX Comparison

LSTA vs CPIX Comparison

Compare LSTA & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

HOLD

Current Price

$1.97

Market Cap

20.9M

Sector

Health Care

ML Signal

HOLD

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

HOLD

Current Price

$4.12

Market Cap

34.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LSTA
CPIX
Founded
1980
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Misc Health and Biotechnology Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.9M
34.1M
IPO Year
N/A
2009

Fundamental Metrics

Financial Performance
Metric
LSTA
CPIX
Price
$1.97
$4.12
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$23.50
N/A
AVG Volume (30 Days)
23.5K
220.6K
Earning Date
11-06-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,070,000.00
$41,278,349.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.21
52 Week Low
$1.81
$1.85
52 Week High
$4.20
$7.25

Technical Indicators

Market Signals
Indicator
LSTA
CPIX
Relative Strength Index (RSI) 39.51 73.82
Support Level $2.00 $3.93
Resistance Level $2.17 $4.59
Average True Range (ATR) 0.10 0.42
MACD 0.01 0.16
Stochastic Oscillator 8.00 80.28

Price Performance

Historical Comparison
LSTA
CPIX

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

Share on Social Networks: